Impaired postprandial tissue regulation of blood flow in insulin resistance: A determinant of cardiovascular risk?

Atherosclerosis

Volumn 147, Issue 1, 1999, Pages 11-15

  Summers, Lucinda K M ^a   Samra, Jaswinder S ^a   Frayn, Keith N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Coronary artery disease; Hypertriglyceridaemia; Insulin resistance; Obesity; Postprandial tissue blood flow

Indexed keywords

CHYLOMICRON; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; NONHUMAN; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0032853293     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00172-0     Document Type: Article

References (48)

1. Flier J.S. An overview of insulin resistance. 1993;1-8 Chichester, Wiley.
2. Reaven G.M. Pathophysiology of insulin resistance in human disease. Physiol Rev. 75:1995;473-486.
3. Ruderman N.B., Schneider S.H., Berchtold P. The 'metabolically-obese', normal-weight individual. Am J Clin Nutr. 34:1981;1617-1621.
4. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
5. Ruderman N.B., Berchtold P., Schneider S. Obesity-associated disorders in normal-weight individuals: some speculations. Int J Obes. 6:1982;151-157.
6. Kannel W.B. Lipids, diabetes and coronary heart disease: insights from the Framingham study. Am Heart J. 110:1985;1100-1107.
7. Turner R.C., Millns H., Neil H.A.W., Stratton I.M., Manley S.E., Matthews D.R. et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS:23). Br Med J. 316:1998;823-828.
8. Austin M.A., Hokanson J.E. Epidemiology of triglycerides, small dense low-density lipoprotein and lipoprotein (a) as risk factors for coronary heart disease. Med Clin North Am. 78:1994;99-115.
9. Jeppesen J., Hollenbeck C.B., Zhou M.Y., Coulston A.M., Jones C., Chen Y.D. et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia. Arterioscler Thromb Vasc Biol. 15:1995;320-324.
10. Patsch J.R. Triglyceride-rich lipoproteins and atherosclerosis. Atheroscerosis. 110:1994;23-26.
11. Ebenbichler C.F., Kirchmair R., Egger C., Patsch J.R. Postprandial state and atherosclerosis. Curr Opin Lipidol. 6:1995;286-290.
12. Miller G.J., Martin J.C., Mitropoulos K.A., Reeves B.E.A., Thompson R.L., Meade T.W. et al. Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis. 86:1991;163-171.
13. Chen Y.L., Messina E.J. Dilation of isolated skeletal muscle arterioles by insulin is endothelium dependent and nitric oxide mediated. Am J Physiol. 270:1996;2120-2124.
14. Scherrer U., Randin D., Vollenweider P., Vollenweider L., Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 94:1994;2511-2515.
15. Steinberg H.O., Brechtel G., Johnson A., Fineberg N., Baron A.D. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 94:1994;1172-1179.
16. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 97:1996;2601-2610.
17. Kearney M.T., Cowley A.J., Stubbs T.A., Macdonald I.A. Effect of a physiological insulin infusion on the cardiovascular responses to a fat meal: evidence supporting a role for insulin in modulating postprandial cardiovascular homeostasis in man. Clin Sci. 91:1996;415-423.
18. Baron A.D., Steinberg H., Brechtel G., Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol. 266:1994;248-253.
19. Baron A.D., Laakso M., Brechtel G., Edelman S.V. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab. 73:1991;637-643.
20. Laakso M., Edelman S.V., Brechtel G., Baron A.D. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest. 85:1990;1844-1852.
21. Baron A.D., Laakso M., Brechtel G., Hoit B., Watt C., Edelman S.V. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab. 70:1990;1525-1533.
22. Baron A.D. Hemodynamic actions of insulin. Am J Physiol. 267:1994;187-202.
23. O'Brien S.F., Watts G.F., Playford D.A., Burke V., O'Neal D.N., Best J.D. Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes. Diab Med. 14:1997;974-978.
24. Hunt S.C., Wu L.L., Hopkins P.N., Stults B.M., Kuida H., Ramirez M.E. et al. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidaemia. Study of Utah patients with familial dyslipidaemic hypertension. Arteriosclerosis. 9:1989;335-344.
25. Reaven G.M., Chen Y.D., Jeppesen J., Maheux P., Krauss R.M. Insulin resistance and hyperinsulinaemia in individuals with small dense low density lipoprotein particles. J Clin Invest. 92:1993;141-146.
26. Selby J.V., Austin M.A., Newman B., Zhang D., Quesenbery C.P.J., Mayer E.J. et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 88:1993;381-387.
27. Bredie S.J.H., Tack C.J.J., Smits P., Stalenhoef A.F.H. Non-obese patients with familial combined hyperlipidaemia are insulin resistant compared with their non-affected relatives. Arterioscler Thromb Vasc Biol. 17:1997;1465-1471.
28. Sniderman A.D., Cianflone K. Substrate delivery as a determinant of apoB secretion. Arterioscler Thromb Vasc Biol. 13:1993;629-636.
29. Coppack S.W., Jensen M.D., Miles J.M. In vivo regulation of lipolysis in humans. J Lipid Res. 35:1994;177-193.
30. Simsolo R.B., Ong J.M., Saffari B., Kern P.A. Effect of improved diabetes control on the expression of lipoprotein lipase in human adipose tissue. J Lipid Res. 33:1992;89-95.
31. Egashira K., Hirooka Y., Kai H., Sugmachi M., Suzuki S., Inou T. et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolaemia. Circulation. 89:1994;2519-2524.
32. Chowienczyk P.J., Watts G.F., Wierzbicki A.S., Cockcroft J.R., Brett S.E., Ritter J.M. Preserved endothelial function in patients with severe hypertriglyceridaemia and low functional lipoprotein lipase activity. J Am Coll Cardiol. 29:1997;964-968.
33. Julien P., Vohl M.C., Gaudet D., Gagné C., Lévesque G., Després J.P. et al. Hyperinsulinaemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency. Diabetes. 46:1997;2063-2068.
34. Simonsen L., Bülow J., Astrup A., Madsen J., Christensen N.J. Diet-induced changes in subcutaneous adipose tissue blood flow in man: effect of beta-adrenoceptor inhibition. Acta Physiol Scand. 139:1990;341-346.
35. Samra J.S., Frayn K.N., Giddings J.A., Clark M.L., Macdonald I.A. Modification and validation of a commercially available portable detector for measurement of adipose tissue blood flow. Clin Physiol. 15:1995;241-248.
36. Summers L.K.M., Samra J.S., Humphreys S.M., Morris R.J., Frayn K.N. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci. 91:1996;679-683.
37. Blaak E.E., van Baak M.A., Kemerink G.J., Pakbiers M.T., Heidendal G.A., Saris W.H. β-Adrenergic stimulation and abdominal subcutaneous fat blood flow in lean, obese and reduced-obese subjects. Metabolism. 44:1995;183-187.
38. Baron A.D., Brechtel G., Wallace P., Edelman S.V. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 255:1988;769-774.
39. Olefsky J.M., Kolterman O.G. Mechanisms of insulin resistance in obesity and non-insulin-dependent (type II) diabetes. Am J Med. 70:1981;151-168.
40. Chung J.W., Suh K.I., Joyce M., Ditzler T., Henry R.R. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM. Diabetes Care. 18:1995;666-673.
41. Shoemaker J.K., Bonen A. Vascular actions of insulin in health and disease. Can J Appl Physiol. 20:1995;127-154.
42. Bülow J., Madsen J. Influence of blood flow on fatty acid mobilization from lipolytically active adipose tissue. Pflüg Arch. 390:1981;169-174.
43. Coppack S.W., Fisher R.M., Gibbons G.F., Humphreys S.M., McDonough M.J., Potts J.L. et al. Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci. 79:1990;339-348.
44. Galitzky J., Lafontan M., Nordenström J., Arner P. Role of vascular alpha-2 adrenoceptors in regulating lipid mobilisation from human adipose tissue. J Clin Invest. 91:1993;1997-2003.
45. Samra J.S., Simpson E.J., Clark M.L., Forster D., Humphreys S.M., Macdonald I.A. et al. Effects of epinephrine infusion on adipose tissue: interactions between blood flow and lipid metabolism. Am J Physiol. 271:1996;834-839.
46. Potts J.L., Coppack S.W., Fisher R.M., Humphreys S.M., Gibbons G.F., Frayn K.N. Impaired postprandial clearance of triacylglycerol-rich lipoproteins in adipose tissue in obese subjects. Am J Physiol. 268:1995;588-594.
47. Feldman R.D., Bierbrier G.S. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet. 342:1993;707-709.
48. Baron A.D., Brechtel-Hook G., Johnson A., Cronin J., Leaming R., Steinberg H.O. Effect of perfusion rate on the time course of insulin-mediated skeletal muscle glucose uptake. Am J Physiol. 271:1996;1067-1072.